Delivery Order SPE2DB24D2100-SPE2DB25FBFCM
Award Date 7/8/25
Potential Completion Date 7/29/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALZENNA 0.35 MG SOFTGEL 30S, a pharmaceutical product, with a total ceiling value of $11,135.25 and a performance period through July 1, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,493.82, is for the delivery of TALZENNA 0.5 MG SOFTGEL 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,784.34 firm fixed-price delivery order is for the supply of TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $21,568.70 and a period of performance through March 7, 2025. It is a firm fixed-price contract and does not have any set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a...
- The Defense Logistics Agency (DLA) awarded a $33,405.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.5 mg softgel capsules (30-count units) on September 16, 2025, with an ultimate completion date of October 7, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract represents a delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for TALZENNA 0.5 mg softgels (30-count units) with a firm fixed price arrangement. The award, issued on September 4, 2025, is scheduled for completion by September 25, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate...
- This federal contract award, valued at $10,784.34, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the medical product TALZENNA 0.5 MG CAPSULE 30S, with a performance period ending on March 27, 2025. The contract is a firm fixed-price arrangement, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Talzenna 0.5 mg softgels (30-count units) under a firm fixed-price contract with a ceiling value of $11.1K. This delivery order, which has no set-aside designation, represents a competitive award and is due for completion by October 20, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $30,008.88, is for the supply of a specialty medication, Talzenna 1 mg capsule, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This award is issued under a larger indefinite delivery contract (IDC) between...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 23, 2025, for the supply of Talzenna 0.25 mg softgel capsules (30-count units) to support federal medical procurement needs. This competitively awarded, non-set-aside contract carries a firm fixed price ceiling value of $22,270.52 with an ultimate completion date of October 15, 2025. The award is funded by the Defense Logistics Agency's Medical...